Women’s health PBAC boost


Endometriosis, OCP drug listings recommended to increase access and multiple treatment options for women The PBAC has recommended unrestricted benefit listings of drospirenone with ethinylestradiol (Yaz and Yasmin) oral contraceptive pills (OCPs) to increase the options available to women who require the drug, used for contraception as well as acne and premenstrual dysphoric disorder. There

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Full-time employment above average in pharmacy
Next World news wrapup: 29 August 2024